Alberta Health Services and The University of Alberta

Edmonton, Alberta T6G 2B7

0 studies enrolling now · 1 studies all time

What they study most

Complete Response, Epithelial Ovarian Cancer, FIGO Stage III-IV, Fallopian Tube Cancer, Newly Diagnosed, Partial Response, Primary Peritoneal

Studies at this site

• A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy — Running, not enrolling